Trials / Recruiting
RecruitingNCT02889016
Neurobiologic, Immunologic, and Rheumatologic Markers in Youth With PANS
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 4 Years – 18 Years
- Healthy volunteers
- Accepted
Summary
This study is an investigation of the neurologic, immunologic, and rheumatologic markers of Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS). PANS is a condition characterized by the abrupt, dramatic onset of obsessive compulsive disorder (OCD) and/or eating restriction accompanied by equally abrupt and severe co-morbid neuropsychiatric symptoms, which include anxiety, emotional lability, depression, irritability, aggression, oppositionality, deterioration in school performance, behavioral (developmental) regression, sensory amplification, movement abnormalities, sleep disturbance, and urinary frequency. PANS is thought to be caused by infection, inflammation, or alternate triggers that is associated with a brain response that leads to these symptoms. The purpose of this study is to examine specific neurologic, immunologic, rheumatologic, and genomic, components in children with the acute-onset of psychiatric symptoms. This research may begin to uncover a much larger story of autoimmune processes that are involved in psychiatric disorders of childhood. By better understanding the etiologic components of psychiatric phenomenon, future treatments may be better targeted to underlying causes.
Detailed description
The investigators will recruit 500 children, 1-18 years old at onset with PANS/PANDAS. They will be treatment naive and within one month of onset/exacerbation. The 500 children with PANS will be gender- and age-matched to 100 healthy children, to allow examination of immunologic, neurologic, genomic, and behavioral differences between these two groups of children.
Conditions
- Pediatric Acute-Onset Neuropsychiatric Syndrome
- Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections
- PANS
- PANDAS
Timeline
- Start date
- 2013-03-01
- Primary completion
- 2028-03-01
- Completion
- 2028-03-01
- First posted
- 2016-09-05
- Last updated
- 2016-10-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02889016. Inclusion in this directory is not an endorsement.